Synthesis and radiolabelling of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl) butyl)-benzamide, a potential dopamine D3 antagonist for SPECT studies

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 46, Issue 5, 2003, Pages 411-419

  Staelens, L ^a,c   Dumont, F ^a   De Vos, F ^b   Oltenfreiter, R ^a   Vandecapelle, M ^a   Dierckx, R A ^b   Slegers, G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Faculty of Pharmaceutical Sciences   (Belgium)

Author keywords

D3 receptor; Dopamine; Radiotracer; SPECT

Indexed keywords

AMIDES; DISEASES; NEUROPHYSIOLOGY;

BENZAMIDES; D3 RECEPTOR; DOPAMINE; IN-VIVO; MENTAL DISORDERS; RADIOLABELLING; RADIOTRACER; RECEPTOR SYSTEM; SPECT; SYNTHESISED;

AMINES;

4 IODO N [4 [4 (2 METHOXYPHENYL)PIPERAZIN 1 YL]BUTYL]BENZAMIDE I 123; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; IODINE 123; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC VALUE; DOPAMINERGIC TRANSMISSION; DRUG STRUCTURE; DRUG SYNTHESIS; HYPERACTIVITY; PATHOLOGY; REACTION ANALYSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ANALYSIS;

EID: 0037398904     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.683     Document Type: Article

References (9)

1. Creese I, Burt D, Snyder S. Science 1976; 192(4238): 481-483.
2. Seemen P, Lee T. Science 1975; 188(4194): 1217-1219.
3. Brücke T, Podreka I, Wenger S. J Cerebral Blood Flow Metab 1991; 11 (S2): S877.
4. Sokoloff P, Giros B, Martres M, Bouthenet M, Schwartz J. Nature 1990; 347: 146-151.
5. Leslie WD, Abrams CR, Greenberg CR, Hobson D. J Nucl Med 1996; 37: 1589-1591.
6. Ishiwata K, Hayakawa N, Ogi N, et al. Ann Nucl Med 1999; 13, 161-167.
7. Chumpradit S, Kung MP, Vessotskie JM, Kung HF. J. Label Compd Radiopharm 1995; 36: 1051-1062.
8. Murray PJ, Harrison LA, Johnson MR et al. Bioorg. Med Chem Lett 1995; 5: 219-222.
9. Pan D, Gatley SJ, Chen R, Ding Y-S. J Label Comp Radiopharm 1996; 6: 523-532.